GENinCode (LON:GENI) Stock Price Down 6.1% – What’s Next?

GENinCode Plc (LON:GENI)’s stock price dropped 6.1% during trading on Wednesday . The company traded as low as GBX 2.20 and last traded at GBX 2.30. Approximately 967,221 shares were traded during mid-day trading, an increase of 63% from the average daily volume of 591,585 shares. The stock had previously closed at GBX 2.45.

GENinCode Trading Down 4.4%

The company has a market cap of £6.31 million, a price-to-earnings ratio of -0.94 and a beta of 0.66. The company’s fifty day moving average price is GBX 2.58 and its two-hundred day moving average price is GBX 2.47. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.